HealthEquity, Inc. (HQY) administers health savings accounts and complementary consumer-directed benefits for employers, benefits advisors, health plans, retirement plan providers, and healthcare consumers. Company updates commonly cover HSA account growth, HSA assets, service, custodial and interchange revenue, guidance, margin measures, stock repurchases, and actions to manage HSA cash repricing exposure.
News also includes board and executive governance changes, investor conference participation, research on healthcare affordability and HSA adoption, and product or platform themes tied to helping members save, spend and invest for healthcare.
HealthEquity (NASDAQ: HQY) plans to release its third-quarter fiscal 2027 financial results after regular stock market trading closes on December 1, 2026. Management will review the results on an investor conference call that day at 4:30 p.m. Eastern Time. A webcast and a replay will be available at ir.healthequity.com.
HealthEquity (NASDAQ: HQY) elected Moody’s Chief Financial Officer Noémie Heuland to its board of directors, effective September 24, 2026. She will also serve on the Audit and Risk Committee and the Cybersecurity and Technology Committee. Her appointment expands the board to 11 directors, nine of whom are independent.
Heuland has served as Moody’s chief financial officer since April 2024. Previously, she was Dayforce’s chief financial officer from October 2020 to February 2024 and spent 12 years in finance leadership roles at SAP. She is a Certified Public Accountant.
HealthEquity (NASDAQ: HQY) reported fiscal 2027 second-quarter revenue of $350.7 million, up 8% year over year, driven by service revenue of $124.4 million, custodial revenue of $175.9 million, and interchange revenue of $50.4 million. Net income rose 10% to $65.6 million, with net income margin improving to 19% from 18%. Diluted EPS increased to $0.78, while non-GAAP diluted EPS reached $1.24. Adjusted EBITDA grew 11% to $167.0 million, representing a 48% margin.
HSAs reached 10.7 million, up 8% year over year, including 0.9 million investment HSAs, and total HSA Assets climbed 14% to $37.9 billion. The company repurchased 1.2 million shares for $108.1 million. According to HealthEquity, full-year fiscal 2027 guidance was raised to revenue of $1.411–$1.421 billion, net income of $242–$248 million, non-GAAP net income of $392–$398 million, and Adjusted EBITDA of $628–$636 million.
HealthEquity (NASDAQ: HQY) will release its second quarter fiscal 2027 financial results before market open on Thursday, August 27, 2026, followed by an investor conference call at 8:30 a.m. Eastern Time. The call offers U.S., Canadian, and international dial-in options and will be webcast at ir.healthequity.com.
A replay will be available on the company’s website. Management also plans to present and meet with investors at the Wells Fargo, Baird, and Deutsche Bank healthcare conferences in September 2026.
HealthEquity (NASDAQ: HQY) released its Spring 2026 Healthcare Affordability Pulse, showing that 36% of Americans delayed or avoided needed medical care in the prior six months due to cost. The survey links affordability pressures to workplace productivity losses and finds HSA holders report stronger financial readiness and control.
HealthEquity (NASDAQ: HQY) reported fiscal 2027 Q1 revenue of $354.6 million, up 7% year over year. Net income rose 29% to $69.4 million ($0.82 diluted EPS), and Adjusted EBITDA increased 17% to $164.5 million with a 46% margin.
HSA assets grew 19% to $37.1 billion. The board expanded the share repurchase authorization by $1.0 billion after buying $123.0 million in Q1. HealthEquity raised its fiscal 2027 outlook, guiding to revenue of $1.410–$1.420 billion and Adjusted EBITDA of $625–$633 million.
HealthEquity (NASDAQ: HQY) will release fiscal 2027 first quarter results after market close on May 28, 2026, followed by a management conference call at 4:30 p.m. ET on the same day. A replay and live webcast will be available at ir.healthequity.com.
Management will also present at investor conferences in May and June 2026, including BofA Health Care (May 12), JP Morgan (May 19), and RBC FinTech (June 9).
HealthEquity (NASDAQ: HQY) appointed William “Bill” Gassen, president and CEO of Sanford Health, to its board effective March 26, 2026. Gassen will join the Audit and Risk Committee and the Talent, Compensation and Culture Committee, expanding the board to 10 directors, eight of whom are independent.
Gassen leads the nation’s largest rural health system and brings operational and payer-provider perspective; he also serves on the board of Oscar Health (NYSE: OSCR).
HealthEquity (NASDAQ: HQY) reported record fiscal 2026 results, including net income $215.2M (+123% YoY), Adjusted EBITDA $566.0M (+20%), and Total HSA Assets $36.5B (+14%). The company added 1.0M new HSAs from sales, repurchased $301.7M of stock, and hedged $2.35B of HSA cash risk. Management raised fiscal 2027 guidance: revenue $1.405B–$1.415B, net income $239M–$246M, non-GAAP net income $392M–$400M, and Adjusted EBITDA $618M–$628M.
Phreesia (NYSE: PHR) appointed Jon Kessler to its Board, effective April 6, 2026, while directors Edward L. Cahill and Michael Weintraub will retire at the 2026 Annual Meeting. The Board will reduce to seven members and a new chair will be named after Weintraub's retirement.
Since the 2019 IPO, revenue grew from about $100 million to over $460 million for the twelve months ended October 31, 2025, and Phreesia enabled roughly 170 million patient visits in 2024.